Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,602Revenue $M443Net Margin (%)59.7Z-Score4.2
Enterprise Value $M1,892EPS $1.7Operating Margin %92.0F-Score3
P/E(ttm))6.0Cash Flow Per Share $1.5Pre-tax Margin (%)90.7Higher ROA y-yN
Price/Book5.410-y EBITDA Growth Rate %0Quick Ratio0.8Cash flow > EarningsN
Price/Sales3.35-y EBITDA Growth Rate %20.0Current Ratio0.8Lower Leverage y-yY
Price/Cash Flow5.0y-y EBITDA Growth Rate %8.2ROA % (ttm)48.6Higher Current Ratio y-yN
Dividend Yield %6.0Insider Buy (3m)0ROE % (ttm)233Less Shares Outstanding y-yN
Payout Ratio %36.0Shares Outstanding M161ROI % (ttm)162Gross Margin Increase y-yN

Gurus Latest Trades with PDLI

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PDLIJohn Hussman 2014-06-30 Sold Out -0.68%$8 - $9.85
($8.9)
$ 10.0913%Sold Out0
PDLIJoel Greenblatt 2014-06-30 Reduce-0.11%$8 - $9.85
($8.9)
$ 10.0913%Reduce -52.58%789,804
PDLIJoel Greenblatt 2014-03-31 Reduce-0.34%$7.46 - $9.14
($8.57)
$ 10.0918%Reduce -50.19%1,665,543
PDLIJohn Hussman 2013-12-31 Reduce-0.49%$7.59 - $10.1
($8.43)
$ 10.0920%Reduce -50.99%1,087,000
PDLIJoel Greenblatt 2013-09-30 Add0.15%$7.72 - $8.44
($8.04)
$ 10.0926%Add 24.84%2,890,564
PDLIJohn Hussman 2013-09-30 Reduce-0.21%$7.72 - $8.44
($8.04)
$ 10.0926%Reduce -21.04%2,218,000
PDLIJoel Greenblatt 2013-03-31 Add0.15%$6.65 - $7.53
($7.08)
$ 10.0942%Add 23.5%2,135,460
PDLIJoel Greenblatt 2012-12-31 Add0.59%$7.09 - $8.37
($7.75)
$ 10.0930%Add 561.89%1,729,133
PDLIJohn Hussman 2012-12-31 Add0.09%$7.09 - $8.37
($7.75)
$ 10.0930%Add 20.19%3,012,000
PDLIJohn Hussman 2012-09-30 Add0.29%$6.59 - $7.73
($7.11)
$ 10.0942%Add 176.91%2,506,000
PDLIJoel Greenblatt 2012-03-31 Add0.04%$6.02 - $6.58
($5.93)
$ 10.0970%Add 33.54%270,346
PDLISeth Klarman 2012-03-31 Sold Out -1.5%$6.02 - $6.58
($5.93)
$ 10.0970%Sold Out0
PDLIJoel Greenblatt 2011-12-31 Add0.04%$5.35 - $6.4
($5.97)
$ 10.0969%Add 31.29%202,444
PDLISeth Klarman 2011-12-31 Reduce-1.4%$5.35 - $6.4
($5.97)
$ 10.0969%Reduce -48.84%8,000,000
PDLIGeorge Soros 2011-12-31 Sold Out -0.001%$5.35 - $6.4
($5.97)
$ 10.0969%Sold Out0
PDLISeth Klarman 2011-09-30 Add1.17%$5.47 - $6.39
($5.91)
$ 10.0971%Add 68.81%15,636,000
PDLIJohn Hussman 2011-09-30 Buy 0.08%$5.47 - $6.39
($5.91)
$ 10.0971%New holding, 905000 sh.905,000
PDLIJoel Greenblatt 2011-09-30 Add0.04%$5.47 - $6.39
($5.91)
$ 10.0971%Add 41.81%154,201
PDLIGeorge Soros 2011-09-30 Buy $5.47 - $6.39
($5.91)
$ 10.0971%New holding, 10000 sh.10,000
PDLIGeorge Soros 2011-06-30 Sold Out $5.74 - $6.64
($6.23)
$ 10.0962%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PDLI is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PDLI Jean-Marie Eveillard 2014-06-302,80000
PDLI Joel Greenblatt 2014-06-30789,8040.490.1-52.58%
PDLI John Hussman 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


PDLI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lindell Jody SDirector 2011-03-15Buy374$5.3389.31view
LARSON CHRISTINE RVice President and CFO 2010-05-14Buy5,000$5.7176.71view
LARSON CHRISTINE RVice President and CFO 2010-04-30Buy10,000$6.1863.27view
KLEIN JOSEPH IIIDirector 2009-11-04Sell24,000$8.3321.13view
Lindell Jody SDirector 2009-06-15Buy3,000$7.7630.03view
SANDMAN PAUL WDirector 2009-04-08Buy10,000$7.3836.72view
SANDMAN PAUL WDirector 2009-04-08Buy10,000$7.3836.72view
KLEIN JOSEPH IIIDirector 2008-05-20Buy500$9.56.21view
KLEIN JOSEPH IIIDirector 2008-05-06Buy500$9.65.1view
KLEIN JOSEPH IIIDirector 2008-04-21Buy500$13.87-27.25view

Press Releases about PDLI :

    Quarterly/Annual Reports about PDLI:

    News about PDLI:

    Articles On GuruFocus.com
    Hot Picks with High Yields Jul 23 2013 
    My 3 Favorite Healthcare Dividend Stocks with Highest Float Short Ratio Jun 03 2013 
    comment on PDLI May 12 2013 
    My 4 Favorites From The 20 Cheapest Healthcare Dividend Stock List May 02 2013 
    FV 22 MSN 10 Apr 19 2013 
    68 Top-Yielding Stocks with Ex-Dividend Date in March 2013 Feb 27 2013 
    20 Best Yielding Healthcare Growth Stocks and Which to Buy Feb 02 2013 
    comment on PDLI Nov 13 2012 
    Seth Klarman’s Investment Framework Sep 15 2012 
    A Look at Two Undervalued Small-Cap Health Care Stocks Aug 09 2012 

    More From Other Websites
    PDL BIOPHARMA, INC. Financials Aug 26 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Aug 19 2014
    PDL BioPharma Misses on Q2 Earnings due to Higher Expenses Aug 19 2014
    PDL BioPharma Announces Second Quarter 2014 and Year to Date Financial Results Aug 18 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 18 2014
    PDL BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report Aug 18 2014
    PDL BioPharma Announces Plans to Issue Second Quarter Financial Results After Market Today and... Aug 18 2014
    Perrigo Regains Some Lost Ground On Fiscal Q4 Beat Aug 14 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events Aug 11 2014
    Q2 2014 PDL BioPharma Earnings Release - After Market Close Aug 11 2014
    PDL BioPharma Announces Delay in Filing Quarterly Report on Form 10-Q Aug 08 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 08 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Aug 06 2014
    PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit Jul 30 2014
    PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014 Jul 28 2014
    Best High-Yielding Stocks According To Greenblatt Principles: PDL BioPharma Jul 11 2014
    PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jul 07 2014
    PDL BioPharma to Participate in Upcoming Investor Conferences Jun 24 2014
    PDL BioPharma: Panning For Dividend Gold Jun 13 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK